Results 161 to 170 of about 1,763 (188)
Some of the next articles are maybe not open access.

Bombarding Oligoprogression

American Journal of Clinical Oncology
Objectives: This study aims to evaluate the efficacy and toxicity of radiotherapy (RT) to oligoprogressive metastatic non–small cell lung cancer (NSCLC). Methods: This is a retrospective analysis of 23 patients with metastatic NSCLC on
Brian, Chou   +5 more
openaire   +2 more sources

Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease

Acta Oncologica, 2022
There is increasing interest in using stereotactic body radiation therapy (SBRT) in areas of oligoprogressive metastatic disease (OPD). Our main objective was to investigate the impact of SBRT on overall survival (OS) and the incidence of systemic therapy treatment switches in this population.A retrospective institutional review of patients treated ...
Sherif Ramadan   +8 more
openaire   +2 more sources

Clinical management of oligoprogressive renal cell carcinoma

Expert Review of Anticancer Therapy
Nearly 81,000 new cases of renal cell carcinoma are expected to be diagnosed in 2025, with more than one-third of patients presenting with or eventually developing metastatic disease. Some patients develop oligoprogressive disease, defined by limited metastatic progression.We discuss current data evaluating the treatment approaches to patients with ...
Ezra A, Bernstein   +5 more
openaire   +2 more sources

[Treatment of oligometastatic or oligoprogression cancer].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2019
We propose in this short review to report the impact of stereotactic body radiation therapy (SBRT) in oligometastatic or oligoprogressive cancer patients in terms of metastatic progression-free and global survival, and to identify the place of SBRT in patient's pathway.
C, Bourgier   +9 more
openaire   +1 more source

Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease

The Cancer Journal, 2020
Abstract The use of local ablative therapy or metastasis-directed therapy is an emerging management paradigm in oligometastatic and oligoprogressive cancer. Recent randomized evidence has demonstrated that stereotactic ablative radiotherapy (SABR) targeting all metastatic deposits is tolerable and can improve progression-free and overall ...
Sondos, Zayed   +2 more
openaire   +2 more sources

Local ablative therapy of oligoprogressive TKI-treated thyroid cancer

Journal of Endocrinological Investigation, 2019
Metastatic cancer patients generally respond well to treatment with tyrosine kinase inhibitors (TKIs). However, TKI resistance occurs in almost all cases and often leads to a change in treatment. Recent guidelines, including thyroid cancer, raised the possibility of locally treating TKI-resistant oligoprogressive disease, i.e., one or a few progressing
Porcelli T.   +3 more
openaire   +3 more sources

Oligometastatic and Oligoprogression Disease

2022
Cynthia Aristei   +3 more
openaire   +1 more source

[Oligometastases and oligoprogressions: Concepts and natural history].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2019
The oligometastatic paradigm refers to an intermediate biologic state of cancer with restricted metastatic capacity. Its phenotype is characterized by a limited number of metastases and a slow tumor growth. Various clinical and pre-clinical studies associated this state to alterations of the biological mechanisms involved in metastatic diffusion ...
P, Annede, C, Chargari
openaire   +1 more source

Oligoprogression

Academic Radiology, 2017
Steven P. Rowe   +3 more
openaire   +1 more source

LOCAL RESECTION OF PERICARDIAL OLIGOPROGRESSIVE MELANOMA

CHEST, 2023
IRVIN LIEN, JEFFREY B VELOTTA
openaire   +1 more source

Home - About - Disclaimer - Privacy